Modena COVID-19 Vaccine U.S. FDA Approved for Emergency Use

The U.S. today granted emergency use authorization for the 2019 coronavirus disease (COVID-19) vaccine developed by Moderna Biotech, paving the way for six million doses of the vaccine to be administered across the United States.

In another critical step in the fight against the global epidemic, the FDA now has two vaccines against COVID-19 available for administration,” said Stephen Hahn, director of the U.S. Food and Drug Administration (FDA).